InvestorsHub Logo
Followers 20
Posts 1261
Boards Moderated 0
Alias Born 04/13/2013

Re: None

Thursday, 05/12/2016 11:22:44 PM

Thursday, May 12, 2016 11:22:44 PM

Post# of 462739
Anavex 2-73 seems to resolve this problem...(from a report over a year ago)

May 12, 2016

University of Adelaide researchers have developed a new theory for the causes of dementia and other neurodegenerative diseases, involving an out-of-control immune system.
Published in the journal Frontiers in Neuroscience, the researchers have assembled strong evidence that the neurological decline common to these diseases is caused by 'auto-inflammation', where the body's own immune system develops a persistent inflammatory response and causes brain cells to die.
http://medicalxpress.com/news/2016-05-rethink-dementia.html



April 7, 2015

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (OTCQX: AVXL) is encouraged by the findings of a new report in the latest issue of peer-reviewed scientific journal Neuroscience Letters. The study demonstrates for the first time through real-time in vivo imaging how microglial inflammation, which is involved in devastating neurodegenerative diseases, can be resolved by sigma-1 receptor activation. The role of sigma-1 receptor activation is to reduce the negative response caused by chronic microglia over-activation, which leads to widespread cell death and multiple neurodegenerative diseases, from brain injury to Alzheimer’s disease.
http://www.anavex.com/?news=anavex-encouraged-by-new-scientific-data-revealing-positive-role-of-sigma-1-receptors-in-brain-injuries
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News